LEIDEN, The Netherlands, Sept. 7,
2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming")
(Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that its Chief
Executive Officer, Sijmen de Vries, will present at the H.C.
Wainwright 24th Annual Global Investment Conference, a
hybrid meeting based in New York,
at the Lotte Palace Hotel, September
12-14, 2022.
Pharming Group N.V.'s CEO will present on Tuesday, September 13 at 09:30 ET / 15:30
CET.
For more information about the conference, or to schedule a
one-to-one with Pharming's management team, please contact your
H.C. Wainwright representative, or send an email to Pharming's
Investor Relations team to investor@pharming.com
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is
a global biopharmaceutical company dedicated to transforming the
lives of patients with rare, debilitating, and life-threatening
diseases. Pharming is commercializing and developing an innovative
portfolio of protein replacement therapies and precision medicines,
including small molecules, biologics, and gene therapies that are
in early to late-stage development. Pharming is headquartered in
Leiden, Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific.
For more information, visit www.pharming.com or follow us
on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, The
Netherlands
Heather Robertson, Investor Relations
& Corporate Communications Manager
T: +31 71 5247 400
E: investor@pharming.com
FTI Consulting, London,
UK
Victoria Foster
Mitchell/Alex Shaw
T: +44 203 727 1000
FTI Consulting, USA
Jim
Polson
T: +1 (312) 553-6730
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon
Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Logo -
https://mma.prnewswire.com/media/1454235/Pharming_Group_NV_Logo.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ceo-of-pharming-to-present-at-hc-wainwright-24th-annual-global-investment-conference-301618483.html
SOURCE Pharming Group N.V.